Can you get Anal Yeast Infections?

Men don't look away this is for everyone. Yeast infections are very common in men and women. The average yeast infection in women is due to too much moisture in the vaginal area causing yeast to multiply out of control.

The acidity levels in the vagina even when returned to normal, cannot always combat a yeast infection. Men can get yeast infections from spermicidal lubricant on condoms. Sexual contact with a man or woman who has a yeast infection is the most common cause. Yeast infections can be transmitted sexually.

How people get an anal yeast infection

The anal area is just as vulnerable to sexually transmitted infections as the rest of the body. Just as a condom containing spermicidal lubricant can give a woman a yeast infection, anal sex on a man can give him an anal yeast infection. This can happen in women as well and is not something that only happens to homosexual couples, anyone who engages in protected or unprotected intercourse is at risk. Yeast infections are also passed through anal intercourse if a male or female has a yeast infection and is not using protection. Just as there is yeast in the vagina and penis, it can also be present in the anus. Showering after intercourse may reduce the risk of a person becoming infected with an anal yeast infection.

What are the Symptoms?

Anal itching is the first symptom of an anal yeast infection, this may not be as apparent because sweat down in the anal area can also cause itching. Redness due to inflammation may also be apparent. A person who has an anal yeast infection may notice purple patches of small blisters.
The anus may feel slightly rough as the skin may be peeling or scaly. Anal yeast infections are commonly seen in those who have a lot of moisture in the anal area, some anal lubricants can almost provide yeast with food if there is any scent or sugar based product in them.

Sperm if ejaculated into the anal canal, may cause a yeast infection in the anus, as sperm is known to have some type of yeast property in it. Some women get a vaginal yeast infection from sperm.

Who is at risk for contracting an anal yeast infection?

Those who engage in anal sex using lubricants, no condoms or condoms with spermicidal lubricant on them are more likely to get a yeast infection of the anus. Those who have many partners are likely to contract an anal yeast infection as they are considered a sexually transmitted infection. The most common way to get a yeast infection is through intercourse. As long as the genitals and anal area are washed with soap and water after foreplay or intercourse the possibility of catching an anal yeast infection from someone is lowered.

Diagnosis and treatment

Diagnosis typically relies on physical examination, KOH microscopy or fungal culture. Treatment options include over-the-counter topical azoles (e.g., clotrimazole, miconazole) for 3–7 days and oral fluconazole or prescription antifungals such as ibrexafungerp if needed

Related Products:

- Hemorrhoids
- Anal Fissures
- Nail Fungus
- Jock Itch
- Athletes Foot

Latest research and expert thinking on yeast infections

Updated Global Guidelines for Candida Infections

• In February 2025, a major international guideline—published in The Lancet Infectious Diseases—set standardized diagnostic and treatment practices for all forms of candidiasis, ranging from superficial infections to invasive disease. It addresses antifungal resistance, emerging species like C. auris, and updates on diagnostics and drug strategies. Read more.

Rising Concern: Drug-Resistant Yeasts and Emerging Species

• Bloodstream infections from yeast—including Candida auris—climbed 4% in England from 2023 to 2024 (2,170 → 2,247 cases). C. auris is notable for its increasing antifungal resistance and high mortality risk. Read more.
  
• A July 2025 single-center study cataloged 15 rare yeast species causing invasive infections, with species-specific antifungal resistance profiles. Mortality at 30 days was ~35% in hospitalized immunocompromised patients. Read more.

Microbiome and Preventive Findings

• Researchers at the Weizmann Institute discovered Kazachstania weizmannii, a commensal yeast that may suppress overgrowth of C. albicans in the gut—raising future potential for microbiome-based prevention strategies. Read more.
  
• A 2025 preprint found vaginal and rectal yeast populations are closely related, suggesting closely linked ecology and transmission dynamics between those sites. Read more.

Alternative & Complementary Treatments

• Studies show coconut oil, garlic‑thyme creams, ozonated olive oil, and tea tree oil may have inhibitory effects on Candida overgrowth—but typically underperform standard azoles in robust comparisons. Probiotics may boost effectiveness when used alongside antifungals, though evidence remains preliminary.

Emerging Therapeutics & Research Directions

• Multiple innovations are under way:
  
• Drug repurposing, AI‑driven diagnostics, improved delivery systems such as combination therapies, along with early-stage antifungals using new mechanisms are being explored to tackle resistant fungi like C. auris and Cryptococcus neoformans. Read more
  
• The Wellcome‑Trust funded project launched mid‑July 2025 aims to develop entirely new drug classes against multidrug‑resistant fungal pathogens, notably C. auris. Read more.
  
• In addition, WHO's first-ever fungal treatment/diagnosis reports (released April 2025) call for urgent R&D and better access to diagnostics—especially in resource-limited settings. Read more.

Key Takeaways for Anal Yeast Infections and Research Context

Topic	Highlights
Anal candidiasis basics	Presents with itching, redness, possible discharge; diagnosed via exam and lab tests. Treatment typically topical azoles or oral antifungals if recurrent or severe.
Why it's researched now	Part of broader emphasis on mucocutaneous candidiasis, resistance, and parallel with vaginal candidiasis in guidelines.
Alternative therapies	While coconut oil, tea tree oil, garlic‑thyme blends offer some promise, they remain less validated than conventional treatments.
Microbiome focus	Innovative research into gut commensals like K. weizmannii may lead to preventive strategies against overgrowth by C. albicans.
Resistance concerns	Rising prevalence of resistant species (like C. auris and non‑albicans Candida) and increased incidence of rare yeasts highlight urgency for better diagnostics and new therapies.

Sources

Di Vito M, et al. (2015). In vitro activity of tea tree oil vaginal suppositories against Candida spp. and probiotic vaginal microbiota. DOI:10.1002/ptr.5422

Fares S, et al. (2017). Effect of ingestion of yogurt containing Lactobacillus acidophilus on vulvovaginal candidiasis among women attending a gynecological clinic. DOI:
10.4103/ENJ.ENJ_8_17